Hypertension Arterial
Conditions
Keywords
sleep apnea, arterial hypertension, cardiovascular risk
Brief summary
The MAPA is the reference method to estimate the PA during the SAHOS. The MAPA can be recommended over 48 hours: indeed, the PA falls at the beginning of every apnea then increases gradually up to a pressif peak arising at the time of the ventilatoire resumption. These variations arise under the influence of 4 stimulus: the désaturation in O2, the rise of the PaCO2, the increase of the respiratory effort and the microawakening of the end of apnea who are at the origin of a sympathetic stimulation. Consequently a better diagnostic approach of the HTA (confirmation of a resistant HTA, an identification of the masked HTA and the patients not dipper by the MAPA), the identification of the SAHOS, and a better coverage) of the associated cardiovascular risk factors are essential and establish a stake in public health. To investigator's knowledge, no datum or study on the association HTA-SAHOS and its consequences was until then realized in the French overseas departments.
Detailed description
In Guadeloupe, data on the relationships between arterial hypertension and obstructive sleep apnea are unavailable. The aim of this study was: to assess the frequency of hypertension and non-dipper pattern evaluated by 48-hour ambulatory blood pressure monitoring in an adult population identified obstructive sleep apnea/non-obstructive sleep apnea during overnight polygraphy ; to determine the cardio-metabolic factors associated with obstructive sleep apnea.
Interventions
OTHERPatient not SAHOS
Phone consultation in 1 month, 3mois, then every 6 months, and an annual visit. * Cardiovascular events arisen during the duration of the study * Modifications of the lifestyle: alcohol, physical activity * Weight * Clinical measure of the PA * Clinical examination * The collection of the cardiovascular events arisen during the duration of the study will be realized for all the inclusive patients
OTHERPatient SAHOS sailed by the ventilation in PPC and not sailed
Questionnaire of subjective evaluation of diurnal slumber: scale of Epworth and search for appearance of at least 2 of the following symptoms: sleep not salvage dealer, night-breathlessnesses, multiple awakenings, fatigue, disordersconfusions, nycturie, snore. * Questionnaire of evaluation of the global quality of life of the SAHOS * Appearance of new cardiovascular risk factors * Cardiovascular events arisen during the duration of the study * Modification of the current treatments * Modifications of the lifestyle: alcohol, physical activity * Weight * Clinical measure of the PA * Clinical examination * The collection of the cardiovascular events arisen during the duration of the study will be realized for all the inclusive patients
Sponsors
Centre Hospitalier Universitaire de la Guadeloupe
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Intervention model description
All the patients will have sampling blood specific to the protocol: * Insulinémie * US CRP(TEACHERS' CENTRE) * Implementation of a sérothèque
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient suspected of SAHOS; * Patient or third-party responsible for receiving information on the study and who signed informed consent ; * Patient age over 18 years; Patient living in Guadeloupe.
Exclusion criteria
* Patient non-affiliated to the social security scheme ; * Patient with obstructive bronchopneumopathy, neuro-muscular pathology, * central and mixed SAS, cardiac arrhythmia, * systemic and chronic inflammatory syndrome ; - * Pregnant and lactating patient ; * patient in emergency.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the frequency of hypertension | At the of the enrollment period, an average of 3 years, etc.). | The primary outcome measure the frequency of hypertension and non-dipper pattern evaluated by 48-hour ambulatory blood pressure monitoring in an adult population identified obstructive sleep apnea/non-obstructive sleep apnea during overnight polygraphy. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The cardio-metabolic factors | through study completion, an average of 8 years | All the enrolled patients will be followed during 5 years and particularly concerning: * the appearance of new risk cardiovascular factors * the advent of cardiovascular events |
Countries
Guadeloupe
Outcome results
None listed